Literature DB >> 24012167

Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.

Seiichi Kato1, Tomoko Miyata, Katsuyoshi Takata, Satoko Shimada, Yoshinori Ito, Akihiro Tomita, Ahmed Ali Elsayed, Emiko Takahashi, Naoko Asano, Tomohiro Kinoshita, Hiroshi Kimura, Shigeo Nakamura.   

Abstract

A 30-year-old female patient presented with intestinal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (EBV+ CTL), which was surgically resected. Fourteen years later, she returned to our hospital with hypersensitivity to mosquito bites and was diagnosed with chronic active EBV infection-associated T/NK-cell lymphoproliferative disorder (CAEBV/TNK-LPD). She developed systemic EBV+ CTL at age 47 years during the 2.5-year clinical course of CAEBV/TNK-LPD, despite multiagent chemotherapy and allogeneic stem cell transplantation. Afterward, she had a rapidly deteriorating clinical course and died at age 48 years. The immunophenotype of the EBV+ CTL was consistently a CD3, CD8, and cytotoxic molecule-positive type with the same clonality in polymerase chain reaction analysis of T-cell receptor-γ chain gene rearrangement. This is the first reported case of EBV+ CTL preceding the clinical presentation of CAEBV/TNK-LPD. The present case was unique in suggesting a close relationship between EBV+ CTL and chronic active EBV infection.
© 2013.

Entities:  

Keywords:  Chronic active Epstein-Barr virus infection; Cytotoxic molecule; Epstein-Barr virus–associated T/NK-cell lymphoproliferative disorders; T-cell lymphoma

Mesh:

Year:  2013        PMID: 24012167     DOI: 10.1016/j.humpath.2013.05.025

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Epstein-Barr virus-associated lymphoproliferative disorder in colon with the development of hemophagocytic syndrome of an immunocompetent patient.

Authors:  Hai-Zhou Wang; Chang Gao; Rui Zhou; Xian-Yan Shi; Ming-Xia Yu; Jun Lin; Qiu Zhao; Jing Liu
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

2.  Necrotizing pancreatitis after removal of prophylactically placed pancreatic stent.

Authors:  Sridhar Sundaram
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

3.  Necrotizing pancreatitis after removal of prophylactically placed pancreatic stent.

Authors:  Sridhar Sundaram
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

4.  Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.

Authors:  Ki Sun Jung; Su-Hee Cho; Seok Jin Kim; Young Hyeh Ko; Won Seog Kim
Journal:  Int J Hematol       Date:  2016-07-25       Impact factor: 2.490

5.  A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Mutsumi Wakabayashi; Hidenori Imai; Yasunobu Sekiguchi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ota; Kengo Takeuchi; Yoshinori Ito; Hiroshi Kimura; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 6.  Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification.

Authors:  Seiichi Kato; Daisuke Yamashita; Shigeo Nakamura
Journal:  J Clin Exp Hematop       Date:  2020

7.  PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: A clinicopathological study of 50 cases.

Authors:  Daisuke Yamashita; Kazuyuki Shimada; Kei Kohno; Yasunori Kogure; Keisuke Kataoka; Taishi Takahara; Yuka Suzuki; Akira Satou; Ayako Sakakibara; Shigeo Nakamura; Naoko Asano; Seiichi Kato
Journal:  Pathol Int       Date:  2020-05-18       Impact factor: 2.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.